Page 6 - இளஞ்சிவப்பு அடிப்படை வெளிப்படுத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இளஞ்சிவப்பு அடிப்படை வெளிப்படுத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இளஞ்சிவப்பு அடிப்படை வெளிப்படுத்தல் Today - Breaking & Trending Today

GNCC Capital, Inc. Has Filed All Outstanding Annual And Quarterly Reports Required To Be PINK CURRENT


Share this article
Share this article
LAS VEGAS, April 5, 2021 /PRNewswire/  GNCC Capital, Inc. (GNCP.PK) ( The Company or GNCC ) confirms that it has today filed all of its outstanding Financial Reports as is required to be PINK CURRENT on the OTC Markets. This includes the Q1 period to December 31, 2020.
Each Financial Report includes the required Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines as is required by the OTC Markets.
We expect that the STOP annotation to the Company will be removed by the OTC Markets within days.
These Financial Reports have been sent to our named outside Counsel for review and for the provision of the Attorney Letter as is required by the OTC Markets. ....

Capital Inc , Financial Reports , Financial Report , Statement Pursuant , Pink Basic Disclosure , Looking Statements , Gncc Capital , மூலதனம் இன்க் , நிதி அறிக்கைகள் , நிதி அறிக்கை , இளஞ்சிவப்பு அடிப்படை வெளிப்படுத்தல் , பார்க்கிறது அறிக்கைகள் ,

Enzolytics, Inc.: Enzolytics Finalizes Documentation with International Medical Partners, Ltd for Clinical Trials and Initial Production of ITV-1 Company Also Provides Update on Year End Reporting


(0)
COLLEGE STATION, TX / ACCESSWIRE / March 16, 2021 / Enzolytics, Inc. (OTC Markets ENZC or the Company ) today announced the formalization of corporate legal documents pursuant to Articles of Association forming International Medical Partners ( IMPL ) a Bulgarian Limited Liability Company of which the Company is 50% owner. The agreements are with the Company s partners in IMBL formed with a group of successful Bulgarian businessmen.
As a team, the Company with IMPL is moving forward to complete the initial production and certification of its ITV-1 patented therapeutics for treating HIV leading to the planned clinical trials under the European Medicine Agency (the EMA ). A commitment for funding of the cost of clinical trials under EMA guidelines and cost associated with the issuance of an EMA permit are part of the negotiated agreements. Under the Mutual Recognition Agreement (the MRA ) between the EMA and the United States Federal Drug Administration (the FDA ), ....

United States , Kostenloser Wertpapierhandel , Harry Zhabilov , Bulgarian Limited Liability Company , Articles Of Association , While Enzolytics Inc , Texasam University , Bioclonetics Immunotherapeutics Inc , Drug Administration , Research Center , United States Federal Drug Administration , International Medical Partners , Enzolytics Inc , European Medicine Agency , Institute For Preclinical , Mutual Recognition Agreement , Clinic Design , European Contract Manufacturing , Report Financial Statements , Pink Basic Disclosure , Basic Disclosure Guidelines , Immune Therapeutic , Inactivated Pepsin Fraction , College Station , Harbor Statement , Medi Cal ,